Doxorubicin Completed Phase N/A Trials for Ovarian Carcinoma

IndicationsStatusPurposePhase
CompletedNot AvailableNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT03562533Real-World Effectiveness of PLD in Platinum- Sensitive Recurrent Ovarian Cancer